Alzheimer’s prevention has become a serious field of research: no treatment cures the disease once it has taken hold, but scientists have identified modifiable factors that can delay its onset or lower the risk of developing it. Alzheimer’s disease affects about 900,000 people in France and remains the leading cause of dementia after age 65, according to Inserm. The 2024 Lancet Commission report attributes 45% of dementia risk to concrete, actionable levers: sleep, hearing, physical activity and cardiometabolic health. This article reviews what the evidence actually shows, and where its limits lie.
In brief – Alzheimer’s prevention targets the modifiable factors behind a neurodegenerative disease that progressively destroys neurons through two main processes: the buildup of beta-amyloid protein plaques and the formation of tau protein tangles inside neurons. Alzheimer’s remains the most common cause of dementia after age 65. The 2024 Lancet Commission report (Livingston et al.) links 45% of dementia risk to 14 modifiable factors spread across the lifespan, including hearing, blood pressure, smoking, obesity, depression, physical inactivity, diabetes, alcohol use, head injury, air pollution and social isolation. None of these levers alone prevents Alzheimer’s disease, but combining them statistically delays its onset. The large FINGER and ACHIEVE clinical trials confirm that acting on several factors at once (sleep, hearing, physical activity, cognitive stimulation) slows cognitive decline in at-risk people, without stopping or reversing it.
Definition: What Is Alzheimer’s Disease?
Alzheimer’s disease is the most common form of dementia in older adults, ahead of vascular dementia and dementia with Lewy bodies. It accounts for roughly two-thirds of dementia cases worldwide, according to the World Health Organization.
The disease progresses through several stages: a silent period lasting years, during which brain lesions accumulate without visible symptoms, followed by mild episodic memory problems, then a progressive decline in language, judgment and independence. Clinical diagnosis typically comes long after the disease’s true biological onset, which explains the growing interest in prevention well before the first symptoms appear.
Mechanisms: How Alzheimer’s Disease Destroys Neurons
The disease stems from a loss of quality control over brain proteins, a mechanism aging biologists call loss of proteostasis. Two misfolded proteins accumulate progressively:
- Beta-amyloid peptide: it forms extracellular plaques that disrupt communication between neurons, years before the first symptoms appear.
- Tau protein: when hyperphosphorylated, it aggregates into tangles inside neurons and disorganizes their internal skeleton, a step that precedes cell death.
- Chronic neuroinflammation: microglia, the brain’s immune system, stay continuously activated in response to these deposits and worsen the damage instead of clearing it.
- Reduced cerebral blood flow: poorly controlled hypertension and diabetes weaken small brain vessels and amplify Alzheimer’s related damage.
These mechanisms take hold decades before diagnosis. That lag makes lifestyle factors relevant early in life, well before the age at which the disease becomes clinically visible.
What the Science Says About Alzheimer’s Prevention
The 2024 Lancet Commission report lists 14 modifiable risk factors associated with 45% of dementia cases worldwide, of which Alzheimer’s disease accounts for the majority (Livingston et al., 2024, The Lancet). Uncorrected hearing loss, midlife hypertension, smoking, obesity, physical inactivity, diabetes, excessive alcohol use, social isolation and air pollution are among the best-documented factors.
The FINGER trial, conducted in Finland among people aged 60 to 77 at risk of cognitive decline, tested a two-year intervention combining diet, exercise, cognitive training and monitoring of vascular risk factors. The intervention group improved 25% more than the control group on overall cognitive score, with larger gains in processing speed and executive function (Ngandu et al., 2015, The Lancet).
On hearing, the ACHIEVE trial followed 977 people aged 70 to 84 with untreated hearing loss. Across the full cohort, hearing aids did not significantly slow cognitive decline. In the subgroup at higher cardiovascular risk, they reduced it by 48% over three years compared with the control group (Lin et al., 2023, The Lancet). This mixed result illustrates why a single isolated measure rarely benefits everyone equally.
Sleep is also among the factors studied. A British cohort of nearly 8,000 civil servants followed for 25 years (Whitehall II) linked persistently short sleep of six hours or less, at ages 50, 60 and 70, to a 30% higher risk of dementia compared with seven hours of sleep, independent of cardiometabolic and mental health factors (Sabia et al., 2021, Nature Communications).
Most of these studies remain observational or limited to specific subgroups. They establish solid associations and a plausible mechanism, not an individual guarantee: following these recommendations lowers the statistical probability of developing Alzheimer’s disease, without eliminating it.
In Practice: The Levers Behind Alzheimer’s Prevention
New World Health Organization guidelines, published in July 2026, consolidate this evidence into practical recommendations (WHO, 2026). The table below summarizes the best-documented levers against Alzheimer’s disease.
| Factor | Scientific evidence | Concrete action |
|---|---|---|
| Hearing loss | Targeted benefit in people at cardiovascular risk (ACHIEVE, 2023) | Hearing screening after age 60, correction if needed |
| Persistently short sleep | Dementia risk +30% with 6 hours of sleep or less from age 50 (Sabia et al., 2021) | Aim for a regular sleep duration of around 7 hours |
| Physical activity and cognitive stimulation | +25% cognitive improvement with multidomain intervention (FINGER, 2015) | Regular walking, continuous learning, an active social life |
| Midlife hypertension | Recognized factor among the 14 levers identified by the Lancet Commission (2024) | Blood pressure monitoring from age 40 to 50 |
| Social isolation | Recognized factor among the 14 levers identified by the Lancet Commission (2024) | Maintaining regular social ties, group activities |
These levers act throughout life, not only after age 60. UltraSante’s Loss of Proteostasis pillar page details other mechanisms linked to the buildup of misfolded proteins during aging. The link between deep sleep and the clearance of brain waste, including beta-amyloid, is covered in our article on brain cleanup during sleep. On the memory front, our feature on ginkgo biloba explains why this supplement has not shown a preventive effect on dementia in large trials.
Protocol: Concrete Action at Every Life Stage
The Lancet Commission report identifies three life periods where prevention levers matter most:
- Before age 45: education level, prevention of head injuries and early obesity.
- Between ages 45 and 65: control of blood pressure, hearing, weight, alcohol consumption and smoking.
- After age 65: maintaining physical activity, cognitive and social stimulation, and preventing depression and physical inactivity.
Our guide on physical activity and longevity details the exercise volumes associated with the best-documented cognitive benefits. None of these steps replace regular medical follow-up, especially for people with a family history of Alzheimer’s disease or early memory problems.
Frequently Asked Questions About Alzheimer’s Prevention
Can Alzheimer’s disease really be prevented?
Not with any guarantee. The 2024 Lancet Commission report links 45% of dementia risk to 14 modifiable factors, leaving a share tied to age, genetics (such as the APOE4 gene) and factors that remain poorly understood. Acting on several levers lowers a statistical probability, without eliminating individual risk.
Does lack of sleep increase the risk of Alzheimer’s disease?
A British cohort of nearly 8,000 people followed for 25 years linked persistently short sleep of six hours or less, at ages 50 and 60, to a 22% to 37% higher risk of dementia depending on age. Deep sleep facilitates the brain’s clearance of beta-amyloid protein, which offers a plausible biological mechanism for this association.
Do hearing aids reduce the risk of dementia?
In the ACHIEVE trial, hearing aids showed no significant effect across all 977 participants. They reduced cognitive decline by 48% over three years in the subgroup at higher cardiovascular risk. The benefit therefore appears concentrated among people already vulnerable on the vascular front.
Do dietary supplements prevent Alzheimer’s disease?
The World Health Organization’s 2026 guidelines do not recommend vitamin B, vitamin E, omega-3s or multivitamins for dementia prevention in the absence of a diagnosed deficiency. No supplement has shown a sufficient preventive effect in large controlled trials.
At what age should you start acting to reduce your risk of Alzheimer’s disease?
As early as possible. The Lancet Commission places relevant levers before age 45 (education, head injuries), between ages 45 and 65 (blood pressure, hearing, alcohol) and after age 65 (physical activity, social life). Alzheimer’s brain lesions begin decades before the first symptoms appear.
Medical disclaimer. This information is provided for informational purposes only and does not constitute medical advice. It does not replace a consultation. Ask a healthcare professional before changing your diet, taking dietary supplements or starting a new practice, especially if you have a medical condition, are pregnant or are under treatment. Dietary supplements do not replace a balanced diet or medical follow-up.
